In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chamomile Extract Drug Master File in Korea (Chamomile Extract KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chamomile Extract. The MFDS reviews the Chamomile Extract KDMF as part of the drug registration process and uses the information provided in the Chamomile Extract KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chamomile Extract KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chamomile Extract API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chamomile Extract suppliers with KDMF on PharmaCompass.